Vertex Diabetes Cell Therapy Trial On Hold – As First Patient Free From Insulin Injections

Company Defends Safety And Reveals Promising Efficacy Data

Vertex expresses surprise at the US FDA’s call for a halt, as it reveals an exciting milestone reached - the first trial participant now producing their own insulin.

Vertex HQ, Boston

More from Clinical Trials

More from R&D